Blood pressure pill joins fight against aggressive prostate cancer
NCT ID NCT07311915
Summary
This study is testing if adding a common blood pressure drug, propranolol, to standard hormone-blocking therapy can better shrink tumors in men with high-risk prostate cancer before they have surgery. The goal is to see if this drug combination leads to less or no detectable cancer in the tissue removed during surgery. The trial will include about 30 men who have not had prior cancer treatment and also have mild to moderate high blood pressure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital
Nanjing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.